Latest News about ARKG
Recent news which mentions ARKG
How Uranium ETFs logged double-digit returns and rare-earth buys shined in Q3, but KraneShares’s China fund tanked
September 30, 2021
From MarketWatch
Mike Khouw Sees Unusual Options Activity In ARK Genomic Revolution ETF
September 29, 2021
Tickers
ARKG
From Benzinga
Why Cathie Wood Is Buying 2 Gene-Editing Stocks but Selling Another
September 23, 2021
From Motley Fool
Cathie Wood Goes Bargain Shopping: 3 Sinking Stocks She Keeps Buying
September 20, 2021
From Motley Fool
Recent Poor Results Have Made This Promising Cathie Wood Pick a Bargain
September 14, 2021
From Motley Fool
3 Cathie Wood Stocks To Trade for Bulls as Well as Bears
September 09, 2021
From InvestorPlace
Google Getting Into Genomics? It Already Is.
September 08, 2021
From ETF Trends
Early Cancer Detection: Major Opportunity for Genomics Investors
September 03, 2021
Tickers
ARKG
From ETF Trends
3 Healthcare Stocks Cathie Wood Loves Right Now
September 03, 2021
From Motley Fool
The Surprising Reason Zymergen Stock Is Soaring Today
August 25, 2021
From Motley Fool
Cathie Wood Stocks: What Names Is ARK Invest CEO Buying Now?
August 17, 2021
From InvestorPlace
From Motley Fool
Cathie Wood's Ark Adds Another $29M To Palantir Stake After Q2 Earnings Beat, Buys DraftKings On Dip
August 15, 2021
From Benzinga
Palantir, Alibaba, Square, Twitter, DraftKings — Stocks Cathie Wood's Ark Bought Or Sold On Thursday
August 13, 2021
From Benzinga
Stock-market investors are banking on this sector in the COVID recovery, while JPMorgan steps up its ETF game
August 12, 2021
From MarketWatch
From Motley Fool
10 Stocks to Buy From Cathie Wood’s Fleet of ETFs
August 06, 2021
From InvestorPlace
Why Zymergen's Stock Is Skyrocketing Today
August 05, 2021
From Motley Fool
From Benzinga
Genomics Advancements Could Aid Breast Cancer Prevention
August 04, 2021
Tickers
ARKG
From ETF Trends
$5,000 Invested in These 3 Healthcare Stocks Could Make You Rich Over the Next 10 Years
August 04, 2021
From Motley Fool
Q2 Growth 'Nothing Short Of Virtuous': Economist
July 29, 2021
From Benzinga
Is This Mid-Cap Biotech Stock a Buy Now?
July 29, 2021
From Motley Fool
Cathie Wood Doubles Down On Teladoc, Spotify, Shopify As Stocks See Earnings-Related Dips
July 29, 2021
From Benzinga
Crispr Therapeutics Has Bullish DNA
July 22, 2021
From InvestorPlace
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
